Spread the loveAs the pharmaceutical industry continues to evolve, marketers must stay abreast of the latest developments and public sentiment that can influence their strategies. As of March 16, 2026 ...

Spread the loveAs the pharmaceutical industry evolves, staying informed about the latest developments is crucial for marketers aiming to create effective strategies. On March 19, 2026, five ...

The pharmaceutical industry is poised for a dynamic year in 2025. A confluence of positive trends suggests a brighter outlook ahead after declining earnings in recent years. According to ZS consultant ...

A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.

From therapeutic complexity, FDA regulatory policy changes, geopolitical shocks and an AI race, life sciences supply chain leaders are forced to rewrite their playbook to stay relevant in the era of ...

How CDMOs are reshaping pharmaceutical partnerships through friendshoring, risk-sharing economics, and specialized development capabilities. The pharmaceutical manufacturing landscape is undergoing a ...

Suzhou Zion Pharma Technology Co. Ltd. has described transcription activator BRG1 (SMARCA4; BAF190A; SNF2-β) and/or probable global transcription activator SNF2L2 (SMARCA2; BAF190B; SNF2-α) inhibitors ...

Ottawa, March 05, 2026 (GLOBE NEWSWIRE) -- The global PET sheets for rigid pharma packaging market size stood at USD 2.38 billion in 2025 and is projected to reach USD 5.04 billion by 2035, according ...

The biopharmaceutical industry loses approximately $35 billion annually due to temperature-control failures within the supply chain, which often results in products being damaged or destroyed.

The pharmaceutical industry is witnessing significant shifts, not only in its research and development processes but also in ...

Using half-baked knowledge in the pharmaceutical world is like trying to launch a rocket without the fuel- It’s bound to fail. The Pharmaceutical industry of India is a Key growth accelerator, and has ...

The pharmaceutical sector is entering 2026 at a critical juncture. While recent initial public offering (IPO) performance has been stellar, with pharma firms claiming five of the top 10 IPO returns ...